A Review of the Management of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease. [PDF]
Raveendran R, Murali V, Fernando H.
europepmc +1 more source
Trajectories of Kidney Function in Autosomal Dominant Polycystic Kidney Disease Patients Treated with Tolvaptan. [PDF]
Jankowska Z, Niemczyk M.
europepmc +1 more source
GLIS3, a novel regulator of eicosanoid gene expression and metabolism in normal kidney and polycystic kidney disease. [PDF]
Srivastava C +8 more
europepmc +1 more source
Congenital Hepatic Fibrosis and/or Autosomal Recessive Polycystic Kidney Disease: A Single-center Experience. [PDF]
Altay D, Yel S, Dursun İ, Arslan D.
europepmc +1 more source
Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease. [PDF]
Lanktree MB +18 more
europepmc +1 more source
Retroperitoneoscopic Nephrectomy at the Time of Kidney Transplantation for Autosomal Dominant Polycystic Kidney Disease: Safety, Efficacy, Feasibility, and Cosmetic Outcomes. [PDF]
Ohyama T +4 more
europepmc +1 more source
Pentosidine and Bone Properties in Autosomal Dominant Polycystic Kidney Disease. [PDF]
Jankowska M +8 more
europepmc +1 more source
Machine Learning Prediction of Progression to Dialysis in Patients With Polycystic Kidney Disease: Population-Based Retrospective Cohort Study. [PDF]
Chang CH +7 more
europepmc +1 more source
Related searches:
Cilia and polycystic kidney disease
Seminars in Cell & Developmental Biology, 2021Polycystic kidney disease (PKD), comprising autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD), is characterized by incessant cyst formation in the kidney and liver. ADPKD and ARPKD represent the leading genetic causes of renal disease in adults and children, respectively.
openaire +2 more sources

